FDA, Amylyx Meeting to Review AMX0035 for Possible Approval
An FDA committee and Amylyx set a virtual meeting for March 30 to review data supporting oral AMX0035's approval request to treat ALS.
0 Comments
FDA, Amylyx Meeting to Review AMX0035 for Possible Approval
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed